Pelvalon Receives FDA Approval for the Eclipse System

Five years of hard work has paid off for the team at Pelvalon.  Last year the FDA had designated the company’s de novo application a Priority Review and today the team received word that FDA has approved the device.  Women suffering from loss of bowel control now have a viable, safe solution to their debilitating condition.  Congratulations to the Pelvalon team!